Drug intelligence / Profile preview

Sanshen Laifu

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Sanshen Laifu (三参来复颗粒) is a traditional Chinese medicine (TCM) formulation presented as granules. The name suggests it contains three types of "shen" (ginseng or similar roots), but there is no official regulatory or clinical documentation available in the provided sources confirming its exact composition, mechanism of action, or approved indications. It does not appear in recent lists of newly approved drugs by the National Medical Products Administration (NMPA), nor in major TCM innovation drug summaries[1][2][3][4]. This suggests that it may be a proprietary product with limited public regulatory information or not yet widely recognized/approved at the national level.

Brand names: Sanshen Laifu三参来复颗粒
Other names: 三参来复颗粒Sanshen Laifu Keli

Beyond the preview

Go deeper on Sanshen Laifu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanshen Laifu.

Explore the full profile